Kasia Gustaw-Rothenberg, MD, PhD

Institute of Agricultural Medicine Case Western Reserve University, Cleveland Heights, OH, United States 
"Kasia Gustaw-Rothenberg"



Mean distance: 18.77 (cluster 28)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Blach-Olszewska Z, Zaczynska E, Gustaw-Rothenberg K, et al. (2015) The innate immunity in alzheimer disease-relevance to pathogenesis and therapy Current Pharmaceutical Design. 21: 3582-3588
Lerner AJ, Gustaw-Rothenberg K, Smyth S, et al. (2012) Retinoids for treatment of Alzheimer's disease. Biofactors (Oxford, England). 38: 84-9
Stone JG, Casadesus G, Gustaw-Rothenberg K, et al. (2011) Frontiers in Alzheimer's disease therapeutics. Therapeutic Advances in Chronic Disease. 2: 9-23
Bojar I, Gustaw-Rothenberg K, Owoc A. (2011) Cognitive functions disorders after a menopause - Still a problem | Zaburzenia funkcji poznawczych po menopauzie - Problem cia̧gle aktualny Przeglad Menopauzalny. 15: 68-73
Gustaw-Rothenberg K, Kowalczuk K, Stryjecka-Zimmer M. (2010) Lipids' peroxidation markers in Alzheimer's disease and vascular dementia. Geriatrics & Gerontology International. 10: 161-6
Gustaw-Rothenberg K, Lerner A, Bonda DJ, et al. (2010) Biomarkers in Alzheimer's disease: past, present and future. Biomarkers in Medicine. 4: 15-26
Gustaw-Rothenberg KA, Siedlak SL, Bonda DJ, et al. (2010) Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Experimental Gerontology. 45: 47-52
Bonda DJ, Wang X, Gustaw-Rothenberg KA, et al. (2009) Mitochondrial Drugs for Alzheimer Disease. Pharmaceuticals (Basel, Switzerland). 2: 287-298
Hardwick A, Rucker JC, Cohen ML, et al. (2009) Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome. Neurology. 73: 2122-4
Lee HP, Casadesus G, Zhu X, et al. (2009) All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Review of Neurotherapeutics. 9: 1615-21
See more...